Last reviewed · How we verify
NCT05651685
Treatment Recommendations for Patients With ADHD TDApp2
trial in Attention Deficit Disorder With Hyperactivity in 32 participants. Completed in 28 June 2024.
28 June 2024
Quick facts
| Lead sponsor | Universitat de Girona |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 32 |
| Start date | 12 December 2022 |
| Primary completion | 28 June 2024 |
| Estimated completion | 28 June 2024 |
| Sites | 1 location across Spain |
Conditions studied
- Attention Deficit Disorder With Hyperactivity — all drugs for Attention Deficit Disorder With Hyperactivity →
Sponsor
Universitat de Girona
Who can join
Adults 6 to 17, any sex, with Attention Deficit Disorder With Hyperactivity. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to compare the recommendations made by TDApp2 with those by relevant clinical practice guidelines in children/adolescents with ADHD.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Assessing TDApp: An AI-based clinical decision support system for ADHD treatment recommendations.
Baykova E, Raya Ò, Lombardía C, Gonzalvo B, et al · · 2025 · cited 1× · PMID 40917247 · DOI 10.3389/fpsyt.2025.1582746
Verify or expand the search:
- PubMed search for NCT05651685
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Attention Deficit Disorder With Hyperactivity
Currently open trials in the same condition.
- NCT06974136 — tES Modalities for the Treatment of ADHD · NA · recruiting
- NCT06764810 — Association Between Motor Skills and Sensory Profiles in Children With Typical and Atypical Development Aged 4 to 11 Yea · recruiting
- NCT05621174 — The Difference in the Mechanism of Action Between Two Brands of Dexamfetamine in Adults With ADHD · NA · active not recruiting
- NCT06369714 — Neurofeedback-Based Digital Therapeutics for the Diagnosis and Treatment of ADHD in Children. · NA · recruiting
- NCT00001246 — Brain Imaging of Childhood Onset Psychiatric Disorders, Endocrine Disorders and Healthy Volunteers · active not recruiting
Other Universitat de Girona trials
Trials by the same sponsor.
- NCT05387291 — Nursing Intervention Program in the Management of Parental Anxiety and Infant Pain in the Surgical Process of Children t · NA · completed
- NCT05096806 — Effects of Semi-standarized Acupuncture in Chronical Symptomatic Osteoarthritis of the Knee Through: A Randomized Contro · NA · unknown
- NCT04228094 — Assesment of TDApp1 an eHelath Tool to Make Therapeutic Recommendations for Patients With ADHD · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05651685 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Universitat de Girona
- Last refreshed: 1 July 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05651685.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing